Crystal Tran

Most-cited papers

1. Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma.

   V. Tchekmedyian, E. Sherman, L. Dunn, Crystal Tran +7 more

   2014Journal of Clinical Oncology198 citations Open access

   Semantic Scholar

   Save

2. A PDX/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening

   Michael L. Beshiri, C. Tice, Crystal Tran, Holly M. Nguyen +11 more

   2018Clinical Cancer Research188 citations Open access

   Semantic Scholar

   Save

3. A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).

   V. Tchekmedyian, E. Sherman, L. Dunn, J. Fetten +10 more

   2019Journal of Clinical Oncology36 citations

   Semantic Scholar

   Save

4. Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate resistant prostate cancer.

   Michael L. Beshiri, Brian J. Capaldo, Ross Lake, Anson T. Ku +13 more

   2024Stem Cells7 citations Open access

   Semantic Scholar

   Save

5. The origin and dynamics of cellular heterogeneity vary across lineage subtypes of castrate resistant prostate cancer

   Michael L. Beshiri, Brian J. Capaldo, R. Lake, Anson T. Ku +13 more

   2023bioRxiv0 citations Open access

   Semantic Scholar

   Save

6. Abstract 6293: Novel approach for automated sequential immunoassay for quantitation and characterization of PI3K-Akt pathway proteins

   I. Kazakova, Crystal Tran, A. Silver, J. Dermody

   2020Experimental and Molecular Therapeutics0 citations

   Semantic Scholar

   Save

7. Abstract 5020: A patient-derived organoid model of neuroendocrine prostate cancer transdifferentiation informing the role of the BAF complex component ARID1A

   Michael L. Beshiri, C. Tice, A. Sowalsky, Crystal Tran +3 more

   2018Tumor Biology0 citations Open access

   Semantic Scholar

   Save

8. Abstract B018: A high-throughput screen identifies HSP90 inhibitors as potent therapeutics across multiple clinically representative organoid models of advanced prostate cancer

   Keith H. Jansson, John B. Tucker, Lauren E. Stahl, J. Simmons +21 more

   2018Poster Presentations - Proffered Abstracts0 citations

   Semantic Scholar

   Save

9. Abstract B051: PDX-derived and patient-derived prostate cancer organoids as a clinically relevant platform for translational research

   Michael L. Beshiri, C. Tice, Crystal Tran, Holly M. Nguyen +10 more

   2018Poster Presentations - Proffered Abstracts0 citations

   Semantic Scholar

   Save

10. Abstract 3065: High-throughput screen identifies HSP90 as a potential therapeutic target in models of advanced CRPC

    Keith H. Jansson, John B. Tucker, Lauren E. Stahl, C. Fuller +19 more

    20170 citations

    Semantic Scholar

    Save

11. Abstract 4838: Optimization of prostate cancer organoid culture methods to grow PDX and human biopsy tissue

    Michael L. Beshiri, Crystal Tran, A. Sowalsky, Holly M. Nguyen +4 more

    20170 citations Open access

    Semantic Scholar

    Save

12. Abstract P1-07-10: Immunohistochemical (IHC) marker discordance between primary breast cancer biopsy and recurrent cancer: Would IHC testing of the surgical breast or lymph node have altered treatment?

    M. Gage, M. Rosman, Charles Mylander, Crystal Tran +2 more

    20150 citations

    Semantic Scholar

    Save